Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05638035

Enrollment

Registered

2022-12-06

Start date

2022-10-15

Completion date

2023-06-15

Last updated

2022-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Sarcopenia, Sarcopenic Obesity

Brief summary

Research; It is a planned, non-invasive, controlled study in obese female volunteers and non-obese female volunteers. The population of the study consists of voluntarily non-obese women and obese women. Sarcopenia assets of individuals will be measured with the sarc-f questionnaire, and then muscle strength, muscle mass and physical performance tests will be measured. Then, rectus femoris muscle thickness will be measured with USG, and then walking and balance will be measured with ZEBRIS.

Interventions

DIAGNOSTIC_TESTUltrasonografi, Sarcopenia measurement, Zebris

The rectus femoris muscle thickness of the participants will be performed in B mode via USG (Mindray-UMT 200,USA) with a multifrequency (7-15 MHz) linear probe and the measurement will be reported. TANITA for sarcopenia, hand grip strength and walking speed will be evaluated. Gait time-distance parameters and Static balance COP parameters (COP speed (cm/s) and COP length (cm)) will be recorded using Zebris™ FDM-2.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Being over 18 years old and female * Volunteering and accepting to participate in the study * BMI 30-39.9 kg/m2 in obese women (experimental group) * BMI 18-27.9 kg/m2 in non-obese women (control group) * Not having cardiorespiratory, neurological, orthopedic and metabolic disorders

Exclusion criteria

* Being under 18 years old and male * Having a BMI of 40.0 kg/m2 and above in obese women (experimental group) * BMI 28.0 kg/m2 and above in non-obese women (control group) * Having cardiorespiratory, neurological, orthopedic and metabolic disorders

Design outcomes

Primary

Measure	Time frame	Description
Rectus femoris muscle thickness	baseline	Measurement of muscle thickness with ultrasound

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026